Coronary Guidewires – Medical Devices Pipeline Assessment, 2020

A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). GlobalData's Medical Devices sector report, “Coronary Guidewires – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Coronary Guidewires Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Coronary Guidewires under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Coronary Guidewires pipeline products.

Review of Recent Developments in the segment / industry

The Coronary Guidewires Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Coronary Guidewires- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Coronary Guidewires under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Coronary Guidewires under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Bioscan Technologies Inc.

Boston Scientific Corp

Cardiovascular Systems Inc

CorMetrics LLC

Echopoint Medical Ltd

ENDOMATERIALS

Georgia Institute of Technology

Guided Interventions, LLC

Infrared Sciences Corp

MaRVis Technologies GmbH

Microbot Medical Ltd

MicroPort Scientific Corp

Opsens Inc

OVALUM Ltd

Philips Volcano

SoundBite Medical Solutions Inc

St. Jude Medical LLC

Terumo Interventional Systems

The Cleveland Clinic Foundation

Three Rivers Cardiovascular Systems Inc

University of Illinois at Chicago

Vasostar Ltd.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Coronary Guidewires Overview 7

3 Products under Development 8

3.1 Coronary Guidewires – Pipeline Products by Stage of Development 8

3.2 Coronary Guidewires – Pipeline Products by Territory 9

3.3 Coronary Guidewires – Pipeline Products by Regulatory Path 10

3.4 Coronary Guidewires – Pipeline Products by Estimated Approval Date 11

3.5 Coronary Guidewires – Ongoing Clinical Trials 12

4 Coronary Guidewires – Pipeline Products under Development by Companies 13

4.1 Coronary Guidewires Companies – Pipeline Products by Stage of Development 13

4.2 Coronary Guidewires – Pipeline Products by Stage of Development 14

5 Coronary Guidewires Companies and Product Overview 15

5.1 Bioscan Technologies Inc. Company Overview 15

5.1.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Boston Scientific Corp Company Overview 16

5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Cardiovascular Systems Inc Company Overview 18

5.3.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 CorMetrics LLC Company Overview 19

5.4.1 CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Echopoint Medical Ltd Company Overview 20

5.5.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 ENDOMATERIALS Company Overview 21

5.6.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Georgia Institute of Technology Company Overview 22

5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 Guided Interventions, LLC Company Overview 23

5.8.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.9 Infrared Sciences Corp Company Overview 24

5.9.1 Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.10 MaRVis Technologies GmbH Company Overview 25

5.10.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 25

5.11 Microbot Medical Ltd Company Overview 26

5.11.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.12 MicroPort Scientific Corp Company Overview 27

5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.13 Opsens Inc Company Overview 28

5.13.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.14 OVALUM Ltd Company Overview 30

5.14.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.15 Philips Volcano Company Overview 31

5.15.1 Philips Volcano Pipeline Products & Ongoing Clinical Trials Overview 31

5.16 SoundBite Medical Solutions Inc Company Overview 32

5.16.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.17 St. Jude Medical LLC Company Overview 35

5.17.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.18 Terumo Interventional Systems Company Overview 36

5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 36

5.19 The Cleveland Clinic Foundation Company Overview 37

5.19.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 37

5.20 Three Rivers Cardiovascular Systems Inc Company Overview 38

5.20.1 Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.21 University of Illinois at Chicago Company Overview 39

5.21.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 39

5.22 Vasostar Ltd. Company Overview 40

5.22.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

6 Coronary Guidewires- Recent Developments 41

6.1 Aug 26, 2020: Cleveland Clinic reaches milestones in heart transplantation and lung transplantation 41

6.2 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical 41

6.3 May 15, 2020: Microport orthopedics group brings in new strategic investors 42

6.4 Apr 16, 2020: Abbott reports first-quarter 2020 results 43

6.5 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 45

6.6 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 46

6.7 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 47

6.8 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 48

6.9 Feb 18, 2020: Medtronic reports third quarter financial results 2020 48

6.10 Feb 14, 2020: Vascular Perspectives and Asahi Intecc form strategic alliance. 51

6.11 Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer 51

6.12 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 51

6.13 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 52

6.14 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 54

6.15 Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020 55

6.16 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 57

6.17 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 57

6.18 Jan 13, 2020: Opsens receives FDA approval of Optowire III 58

6.19 Jan 13, 2020: Opsens – Announces Q1 2020 results 59

6.20 Jan 10, 2020: Cardiva Medical appoints Jeri Hilleman to the company’s Board of Directors 60

6.21 Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. 60

6.22 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 61

6.23 Jan 07, 2020: Cleveland Clinic appoints Lara Jehi, M.D., Chief Research Information Officer 62

6.24 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 63

6.25 Dec 12, 2019: Notice regarding establishment of Overseas Sales Subsidiary Asahi Intecc CIS 63

6.26 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 64

6.27 Nov 21, 2019: Cleveland Clinic names James Merlino, M.D., chief clinical transformation officer 65

6.28 Nov 20, 2019: Former Cleveland Clinic CEO Toby Cosgrove, MD, joins InnovaHealth Partners as Senior Advisor 65

6.29 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66

6.30 Nov 14, 2019: Opsens – Record FY2019 consolidated revenues of $32.8 M, up 36%, Record FFR Revenues of $20M, Up 41% Français 68

6.31 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 69

6.32 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 70

6.33 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 71

6.34 Nov 07, 2019: Opsens – First clinical use of OptoWire III after Health Canada approval 72

6.35 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 73

6.36 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 75

6.37 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 77

6.38 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 78

6.39 Oct 16, 2019: Abbott reports third-quarter 2019 results 79

6.40 Oct 09, 2019: ASAHI INTECC announces opening of medical components website of EU branch 81

6.41 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 82

6.42 Sep 24, 2019: Cardiovascular Systems announces FDA approval of the Coronary ViperWire Advance with Flex Tip 83

6.43 Sep 20, 2019: Terumo to increase production capacity for alliance business 83

7 Appendix 85

7.1 Methodology 85

7.2 About GlobalData 89

7.3 Contact Us 89

7.4 Disclaimer 89

List of Tables

Table 1: Coronary Guidewires – Pipeline Products by Stage of Development 8

Table 2: Coronary Guidewires – Pipeline Products by Territory 9

Table 3: Coronary Guidewires – Pipeline Products by Regulatory Path 10

Table 4: Coronary Guidewires – Pipeline Products by Estimated Approval Date 11

Table 5: Coronary Guidewires – Ongoing Clinical Trials 12

Table 6: Coronary Guidewires Companies – Pipeline Products by Stage of Development 13

Table 7: Coronary Guidewires – Pipeline Products by Stage of Development 14

Table 8: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 9: Lightwire – Product Status 15

Table 10: Lightwire – Product Description 15

Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: COMET II Pressure Guidewire – Product Status 16

Table 13: COMET II Pressure Guidewire – Product Description 17

Table 14: Crossing Wire – Product Status 17

Table 15: Crossing Wire – Product Description 17

Table 16: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 17: ZILIENT Guidewire – Coronary Intervention – Product Status 18

Table 18: ZILIENT Guidewire – Coronary Intervention – Product Description 18

Table 19: CorMetrics LLC Pipeline Products & Ongoing Clinical Trials Overview 19

Table 20: Fractional Flow Reserve Guide Wire System – Product Status 19

Table 21: Fractional Flow Reserve Guide Wire System – Product Description 19

Table 22: Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Table 23: iKOs Guidewire – Coronary – Product Status 20

Table 24: iKOs Guidewire – Coronary – Product Description 20

Table 25: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 21

Table 26: Multimodal Sensing Guidewire – Product Status 21

Table 27: Multimodal Sensing Guidewire – Product Description 21

Table 28: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 22

Table 29: Intravascular Ultrasound Imaging Guidewire – Product Status 22

Table 30: Intravascular Ultrasound Imaging Guidewire – Product Description 22

Table 31: Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Table 32: Pressure Sensing Coronary Artery Guide Wire – Product Status 23

Table 33: Pressure Sensing Coronary Artery Guide Wire – Product Description 23

Table 34: Infrared Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Table 35: Steerable Guidewire – Product Status 24

Table 36: Steerable Guidewire – Product Description 24

Table 37: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 25

Table 38: MaRVis Amber Wire – Product Status 25

Table 39: MaRVis Amber Wire – Product Description 25

Table 40: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Table 41: CardioSert – Double Concentric Guidewire – Product Status 26

Table 42: CardioSert – Double Concentric Guidewire – Product Description 26

Table 43: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 44: Micro-Guide Wire – Product Status 27

Table 45: Micro-Guide Wire – Product Description 27

Table 46: Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 47: OptoWire III – Product Status 28

Table 48: OptoWire III – Product Description 29

Table 49: OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 50: OctoBooster Extension Guidewire – Product Status 30

Table 51: OctoBooster Extension Guidewire – Product Description 30

Table 52: Philips Volcano Pipeline Products & Ongoing Clinical Trials Overview 31

Table 53: ComboWire Plus Pressure And Flow Wire – Product Status 31

Table 54: ComboWire Plus Pressure And Flow Wire – Product Description 31

Table 55: SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 56: SoundBite Active Wire – Coronary – Product Status 32

Table 57: SoundBite Active Wire – Coronary – Product Description 32

Table 58: SoundBite Medical Solutions Inc – Ongoing Clinical Trials Overview 33

Table 59: SoundBite Active Wire – Coronary – A Single-arm Study to Assess the Safety and Efficacy of the SoundBite Crossing System with ACTIVE Wire in Coronary Chronic Total Occlusions (the ACTIVE Trial) 34

Table 60: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 61: Sensor Enabled – Quadra Excel Guidewire – Product Status 35

Table 62: Sensor Enabled – Quadra Excel Guidewire – Product Description 35

Table 63: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 36

Table 64: Wrist Artery Guidewire – Product Status 36

Table 65: Wrist Artery Guidewire – Product Description 36

Table 66: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 37

Table 67: CTO Guidewire – Product Status 37

Table 68: CTO Guidewire – Product Description 37

Table 69: Three Rivers Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 70: SmartGuidewire – Product Status 38

Table 71: SmartGuidewire – Product Description 38

Table 72: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 39

Table 73: CTO Wire – Product Status 39

Table 74: CTO Wire – Product Description 39

Table 75: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 76: Vibrational Guidewire System – Product Status 40

Table 77: Vibrational Guidewire System – Product Description 40

Table 78: Glossary 88

List of Figures

Figure 1: Coronary Guidewires – Pipeline Products by Stage of Development 8

Figure 2: Coronary Guidewires – Pipeline Products by Territory 9

Figure 3: Coronary Guidewires – Pipeline Products by Regulatory Path 10

Figure 4: Coronary Guidewires – Pipeline Products by Estimated Approval Date 11

Figure 5: Coronary Guidewires – Ongoing Clinical Trials 12

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports